Cubist Systematic Strategies LLC Acquires 230,623 Shares of Doximity, Inc. $DOCS

Key Points

• Cubist Systematic Strategies LLC significantly increased its investment in Doximity, Inc., acquiring an additional 230,623 shares, bringing its total holdings to $16.15 million.
• Director Timothy S. Cabral and another director sold a combined 12,000 shares of Doximity stock in recent transactions, indicating potential insider selling trends.
• Analysts have mixed opinions on Doximity's stock, with target prices ranging from $50 to $75 and an average rating of "Moderate Buy."

Cubist Systematic Strategies LLC increased its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 483.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 278,278 shares of the company's stock after buying an additional 230,623 shares during the quarter. Cubist Systematic Strategies LLC owned about 0.15% of Doximity worth $16,148,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. VSM Wealth Advisory LLC acquired a new position in Doximity during the 1st quarter worth approximately $29,000. Allworth Financial LP raised its stake in Doximity by 104.0% during the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after buying an additional 287 shares during the period. National Bank of Canada FI acquired a new position in Doximity during the 1st quarter worth approximately $33,000. Spire Wealth Management increased its holdings in Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after purchasing an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group increased its holdings in Doximity by 70.7% during the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after purchasing an additional 309 shares in the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 10,000 shares of the firm's stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the transaction, the director owned 6,360 shares in the company, valued at $381,600. This trade represents a 61.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the transaction, the director owned 16,618 shares of the company's stock, valued at approximately $948,721.62. This represents a 10.74% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 32,000 shares of company stock valued at $1,929,380. Company insiders own 31.30% of the company's stock.

Doximity Stock Performance

NASDAQ DOCS traded up $1.25 on Thursday, hitting $68.55. 693,138 shares of the stock traded hands, compared to its average volume of 2,264,390. The business's fifty day moving average is $62.34 and its two-hundred day moving average is $60.17. Doximity, Inc. has a 12 month low of $35.32 and a 12 month high of $85.21. The firm has a market capitalization of $12.84 billion, a price-to-earnings ratio of 68.55, a PEG ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter last year, the business earned $0.28 earnings per share. The company's quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts expect that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Analyst Ratings Changes

DOCS has been the subject of a number of recent research reports. Bank of America boosted their price objective on Doximity from $55.00 to $62.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Canaccord Genuity Group boosted their price objective on Doximity from $50.00 to $59.00 and gave the stock a "hold" rating in a report on Friday, August 8th. BTIG Research raised Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price objective for the company in a report on Monday, June 2nd. The Goldman Sachs Group set a $50.00 target price on Doximity and gave the company a "neutral" rating in a report on Wednesday, May 21st. Finally, Raymond James Financial upped their target price on Doximity from $65.00 to $75.00 and gave the company an "outperform" rating in a report on Friday, August 8th. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $66.21.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.